Examples
Worked examples
- Is an instance
A university's designated RIO receives an allegation that a grant-funded dataset was fabricated, determines it meets the FFP definition and falls within PHS jurisdiction, and opens a formal inquiry within the institution's written policy timelines.
- Is an instance
An RIO sequesters a respondent's electronic lab notebook and raw imaging files the same day an inquiry is opened, to preserve the institutional record before any investigation committee is appointed.
Counter-examples
Looks similar, but isn't
- Not an instance
A journal editor investigating a post-publication image-integrity complaint is not acting as an RIO — that role exists only inside the institution that receives PHS support, under 42 CFR Part 93, not at the journal.
- Not an instance
An IRB Chair reviewing a protocol amendment is not performing the RIO function even if the amendment concerns the same study — IRB oversight covers prospective human-subjects protections under the Common Rule, a separate regulatory track from FFP misconduct assessment.
Editorial commentary
The Research Integrity Officer (RIO) is the institutional official a research institution formally designates to receive, initially assess, and administer allegations of research misconduct under 42 CFR Part 93, the U.S. Public Health Service (PHS) research-misconduct regulation. The role is defined in the regulation itself at 42 CFR § 93.233, which describes the RIO as “the institutional official responsible for administering the institution’s written policies and procedures for addressing allegations of research misconduct in compliance with this part.”
Any institution that applies for or receives PHS support — funding that flows through NIH, CDC, FDA, HRSA, and other PHS agencies — must have a written misconduct policy on file and must name a specific RIO to administer it. This is not an optional best practice; it is a condition of eligibility for PHS-funded research.
What the role actually requires
An institution “having” an RIO is not enough to satisfy 42 CFR Part 93 — the designation has to translate into the person actually performing the regulation’s operational steps when an allegation surfaces. At minimum, the RIO is responsible for:
- Receiving allegations of possible research misconduct (fabrication, falsification, or plagiarism — the FFP definition set out at 42 CFR § 93.234), from any source, and documenting them.
- Conducting the initial assessment — determining whether an allegation, on its face, falls within the regulation’s definition of research misconduct, falls within the institution’s jurisdiction, and is sufficiently credible and specific to warrant further action.
- Deciding whether an inquiry is warranted and, if so, initiating it — the formal, time-boxed preliminary review (42 CFR § 93.215) that determines whether a full investigation is justified.
- Sequestering relevant research records promptly once an inquiry begins, to prevent loss or alteration of evidence.
- Appointing the inquiry and, where warranted, investigation committees, and overseeing that they follow the institution’s written procedures and the regulation’s timelines.
- Maintaining the institutional record of the proceeding and coordinating the institution’s reporting obligations to the HHS Office of Research Integrity (ORI).
ORI’s own role is oversight, not first-line fact-finding: it reviews an institution’s findings, can request additional information or a re-opened inquiry, and makes the final administrative-action determination in PHS cases — but the RIO, not ORI, runs the process on the ground. See How a Research Misconduct Investigation Actually Works for the full inquiry-to-investigation sequence the RIO administers.
How the RIO differs from other institutional roles
The RIO is frequently confused with adjacent compliance and oversight roles that have genuinely different scopes:
- Institutional Deciding Official (IDO) — a separate role under the same regulation (42 CFR § 93.218) responsible for reviewing the investigation committee’s findings and deciding what administrative action, if any, the institution takes. The RIO administers the process up to and through the investigation; the IDO decides its outcome. Institutions must keep these functions distinct precisely so the person who ran the inquiry is not also the person unilaterally deciding the sanction.
- IRB Chair — oversees prospective, protocol-level human-subjects protections under the Common Rule; has no role in FFP misconduct allegations unless a specific concern also happens to implicate human-subjects protections, in which case the two processes run in parallel, not interchangeably.
- Compliance Officer / Research Compliance Office — typically a broader role covering export controls, conflict of interest, financial compliance, and grants administration generally. An institution may house the RIO function inside a compliance office administratively, but the RIO’s specific 42 CFR Part 93 duties are a distinct, regulation-defined function, not a synonym for general compliance oversight. See The 7 Elements of an Effective Compliance Program for how misconduct response fits into the broader compliance structure.
- Institutional Certifying Official — a different, narrower 42 CFR Part 93 role (§ 93.217) focused on certifying to ORI that the institution has complied with the regulation’s requirements in a given case; may or may not be the same individual as the RIO depending on institutional structure.
Worked example
A postdoctoral fellow emails an institution’s designated RIO alleging that a co-author manipulated a Western blot image in a PHS-funded manuscript. The RIO logs the allegation, conducts the initial assessment against the FFP definition and PHS-funding jurisdiction, and — finding it credible and specific — opens a formal inquiry, sequesters the relevant lab notebooks and image files, and appoints an inquiry committee under the institution’s written policy. If the inquiry concludes an investigation is warranted, the RIO oversees that phase too, while the separate Institutional Deciding Official is the one who ultimately decides on any sanction once the investigation committee reports its findings.
Counter-example
A journal editor who receives a post-publication image-integrity complaint and asks the corresponding author’s institution to look into it is not acting as an RIO — the editor has no PHS Part 93 role at all. Once the institution receives that referral, it is the institution’s own designated RIO, not the editor or the journal, who must conduct the assessment and decide whether an inquiry is warranted.
Related terms
- Research misconduct
- Fabrication
- Falsification
- Plagiarism
- ORI (US Office of Research Integrity)
- Conflict of Interest (COI) in Research
References
- 42 CFR Part 93, Subpart B — Definitions, § 93.233 (Research Integrity Officer or RIO), § 93.218 (Institutional Deciding Official), § 93.217 (Institutional Certifying Official), § 93.215 (Inquiry), § 93.234 (Research misconduct). U.S. Department of Health and Human Services, via eCFR.gov.
- HHS Office of Research Integrity (ori.hhs.gov), RIO Handbook for Institutional Research Integrity Officers.
Machine-readable encodings
Use in your systems
<role vocab="credit"
vocab-identifier="https://casrai.org/dictionary/"
vocab-term="Research Integrity Officer (RIO)"
vocab-term-identifier="https://casrai.org/dictionary/term/research-integrity-officer-rio" />{
"@context": "https://schema.org",
"@type": "DefinedTerm",
"@id": "https://casrai.org/dictionary/term/research-integrity-officer-rio",
"name": "Research Integrity Officer (RIO)",
"identifier": "https://casrai.org/dictionary/term/research-integrity-officer-rio",
"description": "The institutional official a research institution formally designates, per 42 CFR § 93.233, to administer its written research-misconduct policy: receiving allegations, conducting the initial assessment of whether they meet the fabrication/falsification/plagiarism definition and fall within institutional jurisdiction, deciding whether to open a formal inquiry, sequestering relevant research records, and appointing inquiry/investigation committees. Institutions that apply for or receive PHS support (NIH, CDC, FDA, and other Public Health Service funding) must designate an RIO as a condition of that support.",
"inDefinedTermSet": "https://casrai.org/dictionary/domain/compliance-regulatory#set",
"url": "https://casrai.org/dictionary/term/research-integrity-officer-rio",
"sameAs": [],
"license": "https://creativecommons.org/licenses/by/4.0/",
"publisher": {
"@id": "https://casrai.org/#organization"
},
"dateModified": "2026-07-18T10:38:01",
"inLanguage": "en"
}






